Molecular Pharmacology, Vol 17, 1-7, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

A Comparison of the Beta-Adrenergic Receptor of the Turkey Erythrocyte with Mammalian Beta₁ and Beta₂ Receptors

¹ Department of Pharmacology, University of Colorado Medical Center, 4200 East Ninth Avenue, Denver, Colorado 80262

The kinetic and pharmacological properties of -adrenergic receptors in turkey erythrocyte membranes have been characterized by measuring adenylate cyclase activity and specific binding of ¹²⁵I-iodohythoxybenzylpindolol (IHYP). Receptor properties have been compared to those of ₁, and ₂ receptors in a number of mammalian tissues. The affinity (K_D) of IHYP for the turkey erythrocyte -adrenergic receptor (42 pM) was similar to the K_D for IHYP binding to either ₁ or ₂ receptors. However, the rates of both association (k₁) and dissociation (k_-1) of IHYP were 6-10 times faster when measured with -adrenergic receptors on turkey erythrocytes than were observed for either ₁ or ₂ receptors in various mammalian tissues. Thermodynamic analysis of the k₁ for IHYP binding in the turkey erythrocyte and rat heart showed similar enthalpies of activation (H), suggesting that the different k₁ values arise mainly from different entropies of activation (H) in the two tissues. The order of potency of drugs for activation or inhibition of adenylate cyclase activity correlated well with that for inhibition of IHYP binding in the turkey erythrocyte. However, both the K_i and K_act values for adenylate cyclase were generally two to three times higher than the corresponding K_D value determined from studies of the inhibition of IHYP binding. The pharmacological effects of a variety of drugs with similar or different affinities for ₁- and ₂-adrenergic receptors were determined on membranes prepared from turkey erythrocytes. The K_D values for nonselective drugs in the turkey erythrocyte were identical to their K_D values for ₁, and ₂ receptors, suggesting that this receptor should be classified as a -adrenergic receptor. However, the K_D values in the turkey erythrocyte for selective drugs did not correlate with the K_D values for these drugs at either ₁ or ₂ receptors. Furthermore, the efficacies of partial agonists at turkey erythrocyte -adrenergic receptors did not correlate with their efficacies for either ₁ or ₂ receptors. The results demonstrate that the -adrenergic receptor in the turkey erythrocyte has kinetic and pharmacological properties distinct from either mammalian ₁ or ₂ receptors.

Note:
ACKNOWLEDGMENTS We thank Beth Goens for excellent technical assistance and Candace Plesha for preparing the manuscript.

This article has been cited by other articles:

				M. J. Serrano-Vega, F. Magnani, Y. Shibata, and C. G. Tate Conformational thermostabilization of the {beta}1-adrenergic receptor in a detergent-resistant form PNAS, January 22, 2008; 105(3): 877 - 882. [Abstract] [Full Text] [PDF]

				Q. Li, M. Olesky, R. K. Palmer, T. K. Harden, and R. A. Nicholas Evidence that the p2y3 Receptor Is the Avian Homologue of the Mammalian P2Y6 Receptor Mol. Pharmacol., September 1, 1998; 54(3): 541 - 546. [Abstract] [Full Text]

				E. M. Parker, P. Swigart, M. H. Nunnally, J. P. Perkins, and E. M. Ross Carboxyl-terminal Domains in the Avian beta(1)-Adrenergic Receptor That Regulate Agonist-promoted Endocytosis J. Biol. Chem., March 24, 1995; 270(12): 6482 - 6487. [Abstract] [Full Text] [PDF]

				J. Wang and E. M. Ross The Carboxyl-terminal Anchorage Domain of the Turkey beta(1)-Adrenergic Receptor Is Encoded by an Alternatively Spliced Exon J. Biol. Chem., March 24, 1995; 270(12): 6488 - 6495. [Abstract] [Full Text] [PDF]